newsfilter
← Latest News
Business Wire·

Arcellx Provides First Quarter 2024 Financial Results

Arcellx, Inc. (NASDAQ:ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported business